Quick Answer
AIM ImmunoTech Inc. reported Long Term Debt of $1.88 million for the year ending 2020.
- AIM ImmunoTech Inc. showed a decrease of -10.8% in Long Term Debt from 2019 to 2020.
- This data is from AIM ImmunoTech Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2022.
- XBRL data for this metric is available from 2018 to 2020 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2018: $2.44 million | Q2 2018: $2.42 million | Q3 2018: $2.37 million | Q1 2019: $2.27 million | Q2 2019: $2.21 million | Q3 2019: $2.16 million | Q1 2020: $2.05 million | Q2 2020: $1.99 million | Q3 2020: $1.93 million | Q1 2021: $1.82 million.
- Over the full 3 years of available data (2018 to 2020), AIM ImmunoTech Inc.'s Long Term Debt has declined by 19.1%.
- Historical annual values: Fiscal year 2020: $1.88 million | Fiscal year 2019: $2.10 million | Fiscal year 2018: $2.32 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: